Abstracts (HTML) List of Authors

Nadzemova, Oksana

Korrektur der Morbus Wilson Punktmutation H1069Q in iPSCs mittels CRISPR/Cas9 Genom-Editierung

Namer, Barbara

Multimodal assessment of the skin-nerve-axis identifies specific patterns in patients with cholestatic liver disease-associated pruritus

Nardone, Luigi

Circulating tumor cells predict recurrence risk in early HCC treated with local ablative therapy

Nattermann, Jacob

Microbial detection in peritonitis may be faster by automated molecular methods, but less sensitive, which also depends on cause of peritonitis

Navas, Maria Cristina

Mobile Ultrasound Screening Program for MASLD in High Cardiovascular Risk Communities in Rural Colombia: Initial Results

Nayagam, Jeremy

Safety and efficacy of Upadacitinib in patients with primary sclerosing cholangitis: a multicentre, retrospective study

Neckermann, Lukas

Multi-Omics Gene Signatures Predict Disease Trajectory in a Cholestasis-Based ACLF Mouse Model

Negro, Alejandra

Five-year overall survival (OS) and OS by tumour response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)

Neumaier, Michael

Comparative evaluation of standard machine learning models for liver fibrosis detection

Neumann, Ulf Peter

HOPE treatment prior to organ transplant alters key immune modulators in patients receiving liver transplantation

Neumann-Haefelin, Christoph

Skewed HBV-specific CD8+T cell repertoire in chronic versus acute-resolving HBV infection

Neumeyer, Katja

Targeting p53 Isoforms: A Novel Approach for Anticancer Therapy

Neurath, Markus F.

Multimodal assessment of the skin-nerve-axis identifies specific patterns in patients with cholestatic liver disease-associated pruritus

Nickel, S.

Abstract for section “Clinical Hepatology, Surgery, LTX”

Niehaus, Christian

Granzyme profiles in CXCR6+PD-1+CD8+T cells differentiate acute and chronic hepatitis flares and may reflect intrahepatic immune imprints
Immune activation as a hallmark in liver disease progression
Non-Selective Beta Blockers Reduce Inflammatory Bystander CD8+T Cell Activation in Decompensated Cirrhosis

Nieves, Wildaliz

Bulevirtide in combination with pegylated interferon alfa-2a shows a sustained off-treatment response in the liver

Niklisch, Saskia

Association of the Genetic Variant VEGFA rs3025039 with Incidence and Prognosis of Cholangiocarcinoma

Nkongolo, Shirin

Deconvoluting the spatial immune landscape in the Hepatitis B Virus infected human liver at single-cell resolution

Nordmann, Tamara

Incidence and risk factors of DILI in Ethiopian patients receiving tuberculosis treatment – do polymorphisms of hepatic transporter proteins play a role?

Noureddin, Mazen

Liver enzymes reductions from baseline over time in resmetirom treated patients in a Phase 3 study, MAESTRO-NASH

Nteliopoulos, Georgios

Characterization of T cell subsets and dynamic remodeling following immune checkpoint inhibition in hepatocellular carcinoma

Nuruzade, Nargiz

Effekt der IL-17-Interleukin-Familie auf die Blutgerinnung bei Patienten mit akut dekompensierter Leberzirrhose, bewertet mittels Restricted Cubic Splines

Nüssler, Andreas

In vitro characterization of the drug metabolizing capacity of hepatocytes from MASH livers and development of a PK model for MASH patients